Literature DB >> 17765532

Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade.

Martijn A Spruit1, Herman-Jan Pennings, Paul P Janssen, Joan D Does, Sigrid Scroyen, Marco A Akkermans, Rob Mostert, Emiel F M Wouters.   

Abstract

Experts have stated that referral for rehabilitation of patients with chronic obstructive pulmonary disease (COPD) becomes appropriate when these patients become aware of their disability (e.g. usually grade 3 to 5 on the Medical Research Council (MRC) dyspnea scale). However, patients with MRC dyspnea grade 1/2 may also suffer from extra-pulmonary features, such as abnormal body composition, exercise intolerance and reduced disease-specific health status. In the present study, we have studied whether and to what extent chronic obstructive pulmonary disease (COPD) patients with MRC dyspnea grade 1/2 have extra-pulmonary features compared to patients with grade 3, 4 or 5? Pulmonary function, body composition, 6-min walking distance, peak exercise capacity, anxiety, depression and disease-specific health status have been assessed in 333 outpatients who had been referred for pulmonary rehabilitation. On average, patients with MRC dyspnea grade 1/2 had a better exercise tolerance and disease-specific health status compared to patients with grade 4 or 5. Nevertheless, grade 1/2 patients had a higher prevalence of muscle mass depletion. In addition, these patients did still have aberrant values in one or more of the aforementioned outcomes. On average, patients with MRC dyspnea grade 1/2 may clearly suffer from extra-pulmonary features, indicating the necessity to refer these patients for rehabilitation. Therefore, MRC dyspnea scale alone does not appear to be a suitable measure to identify most patients with COPD who have to be referred for rehabilitation.

Entities:  

Mesh:

Year:  2007        PMID: 17765532     DOI: 10.1016/j.rmed.2007.07.003

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

1.  The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.

Authors:  Sarah Wilke; Dionne E Smid; Martijn A Spruit; Daisy J A Janssen; Jean W M Muris; Thys van der Molen; Marjan van den Akker; Paul W Jones; Emiel F M Wouters; Frits M E Franssen
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study.

Authors:  Elizabeth C Oelsner; Joao A C Lima; Steven M Kawut; Kristin M Burkart; Paul L Enright; Firas S Ahmed; R Graham Barr
Journal:  Am J Med       Date:  2014-10-15       Impact factor: 4.965

3.  Oxygen uptake, ventilation, and symptoms during low-frequency versus high-frequency NMES in COPD: a pilot study.

Authors:  Maurice J H Sillen; Emiel F M Wouters; Frits M E Franssen; Kenneth Meijer; Koen H P Stakenborg; Martijn A Spruit
Journal:  Lung       Date:  2010-11-16       Impact factor: 2.584

4.  Effectiveness of a 4-week rehabilitation program on endothelial function, blood vessel elasticity in patients with chronic obstructive pulmonary disease.

Authors:  Botond Szucs; Mate Petrekanits; Janos Varga
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

6.  Nordic walking improves daily physical activities in COPD: a randomised controlled trial.

Authors:  Marie-Kathrin Breyer; Robab Breyer-Kohansal; Georg-Christian Funk; Nicole Dornhofer; Martijn A Spruit; Emiel F M Wouters; Otto C Burghuber; Sylvia Hartl
Journal:  Respir Res       Date:  2010-08-22

7.  Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.

Authors:  Cornelia A Verberkt; Marieke H J van den Beuken-van Everdingen; Jos M G A Schols; Niels Hameleers; Emiel F M Wouters; Daisy J A Janssen
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

8.  Task-related oxygen uptake and symptoms during activities of daily life in CHF patients and healthy subjects.

Authors:  Martijn A Spruit; Emiel F M Wouters; Rose-Mieke A Eterman; Kenneth Meijer; Scott S Wagers; Koen H P Stakenborg; Nicole H M K Uszko-Lencer
Journal:  Eur J Appl Physiol       Date:  2011-01-06       Impact factor: 3.078

9.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity.

Authors:  J M Seymour; M A Spruit; N S Hopkinson; S A Natanek; W D-C Man; A Jackson; H R Gosker; A M W J Schols; J Moxham; M I Polkey; E F M Wouters
Journal:  Eur Respir J       Date:  2009-11-06       Impact factor: 16.671

10.  Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.

Authors:  Sarah Wilke; Daisy J A Janssen; Emiel F M Wouters; Jos M G A Schols; Frits M E Franssen; Martijn A Spruit
Journal:  Health Qual Life Outcomes       Date:  2012-08-21       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.